February 10, 2014

Merck to offer 100 million settlement in NuvaRing lawsuits

Merck to offer $100 million settlement in NuvaRing lawsuits
Merck will pay $100 million to settle thousands of lawsuits over the company's NuvaRing birth control device, according to insiders.

(HealthDay)—Merck will pay $100 million to settle thousands of lawsuits over the company's NuvaRing birth control device, according to insiders.

The will be announced Friday and provide an average payout of more than $58,000 per case, two people familiar with the told Bloomberg News. They did not want to be identified because they hadn't been authorized to talk publicly about the accord.

The deal will resolve several thousand cases in federal and state courts in Missouri and New Jersey. Women accused Merck of selling NuvaRing even though the company knew that the device put them at higher risk for than products from other companies.

A Merck spokeswoman declined to comment on the settlement, Bloomberg reported.

More information: Other Health Highlights: Feb. 7, 2014

Copyright © 2014 HealthDay. All rights reserved.

Citation: Merck to offer 100 million settlement in NuvaRing lawsuits (2014, February 10) retrieved 18 April 2024 from https://medicalxpress.com/news/2014-02-merck-million-settlement-nuvaring-lawsuits.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Merck will pay $950M to settle Vioxx investigation
 shares

Feedback to editors
Human cases of bird flu 'an enormous concern': WHO

38 minutes ago
Perfect balance: How the brain fine-tunes its sensitivity

58 minutes ago
New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies

59 minutes ago
Researchers reduce bias in pathology AI algorithms and enhance accuracy using foundation models

59 minutes ago
Responsiveness to ADHD treatment may be determined by neuroanatomy

1 hour ago
Study shows metabolic health before vaccination determines effectiveness of anti-flu response

1 hour ago
New heart disease calculator could save lives by identifying high-risk patients missed by current tools

1 hour ago
Study finds promising biomarker for cellular rejection after organ transplant

1 hour ago
Potential new treatment strategy for aggressive leukemia

1 hour ago
Siblings with unique genetic mutation help scientists progress drug search for type 1 diabetes

1 hour ago
Load comments (0)